Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ 103,430
▲ 312% vs 2024
Profit
Caution€ -528,922
▲ 11% vs 2024
Debts
Normal€ 2.4 million
▲ 68% vs 2024
XomeXBio from Charleroi, company number BE0801880687, closed financial year 2025 with a result of € -528,922 after tax. For that financial year XomeXBio recorded a gross margin of € 103,430 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -595,305 to € -528,922. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
What happened at XomeXBio?
What happened at XomeXBio in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 528,922. Source: NBB ↗
- Hui Yang became a director. NBB
- TONGLET CONSULT became a director. NBB
- Chen Sihui became a director. NBB
- New establishment in Charleroi. KBO
- JPP CONSULTING became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 6,337 loss in 2023 to € 528,922 loss in 2025.
Paid € 799 in corporate taxes since 2023.
On average € 25,900 of value added per employee in 2025.
A new publication or filing at XomeXBio? We notify you, reason included.
Follow XomeXBioNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind XomeXBio are Hui Yang, JPP CONSULTING, TONGLET CONSULT and Chen Sihui. The same people are also behind CURAVAC EUROPE, PDC line Pharma, ConvEyXo and Exo-Harvest.
Directors
According to the 2025 annual accounts
Hui Yang
Director
since 2024
Director · represented by Jean PRIEELS
Also active at: CURAVAC EUROPE, PDC line Pharma, ConvEyXo +1 more
since 2023
since 2024
Chen Sihui
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
Details
- Company number
- 0801.880.687
- VAT number
- BE 0801.880.687
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- XomeXBio
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 May 2023
- Peppol
- Active · Active since 5 Jun 2023
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied